Patent classifications
C12P7/00
Antimicrobial compositions and related methods of use
Antimicrobial compositions comprising one or more compound components generally recognized as safe for human consumption, and related methods of use, such compositions and methods as can be employed in a wide range of agricultural, industrial, building, pharmaceutical and/or personal care products and applications.
Process for degrading mannan-containing cellulosic materials
The present invention relates to processes comprising enzymatic degradation of mannan-containing cellulosic materials for producing a hydrolyzate. The invention also relates to processes of producing a fermentation product from mannan-containing cellulosic materials.
Process for degrading mannan-containing cellulosic materials
The present invention relates to processes comprising enzymatic degradation of mannan-containing cellulosic materials for producing a hydrolyzate. The invention also relates to processes of producing a fermentation product from mannan-containing cellulosic materials.
Antimicrobial compositions and related methods of use
Antimicrobial compositions comprising one or more compound components generally recognized as safe for human consumption, and related methods of use, such compositions and methods as can be employed in a wide range of agricultural, industrial, building, pharmaceutical and/or personal care products and applications.
Antimicrobial compositions and related methods of use
Antimicrobial compositions comprising one or more compound components generally recognized as safe for human consumption, and related methods of use, such compositions and methods as can be employed in a wide range of agricultural, industrial, building, pharmaceutical and/or personal care products and applications.
Reduction of oxidated methionine peptides for mass spectrometry
A method for preparing a methionine containing peptide or protein for analysis by mass spectrometry by incubating the methionine containing peptide or protein with a heterologous methionine sulfoxide reductase A (MsrA), a heterologous methionine sulfoxide reductase B (MsrB), or a heterologous methionine sulfoxide reductase AB (MsrAB) enzyme results in the reduction of an oxidized methionine containing peptide or protein.
EPOXIDATION USING PEROXYGENASE
The invention relates to enzymatic methods for epoxidation of a non-cyclic aliphatic alkene, or a terpene.
EPOXIDATION USING PEROXYGENASE
The invention relates to enzymatic methods for epoxidation of a non-cyclic aliphatic alkene, or a terpene.
METHOD FOR PRODUCING ULTRAFINE-BUBBLE-CONTAINING LIQUID AND APPARATUS FOR PRODUCING ULTRAFINE-BUBBLE-CONTAINING LIQUID
A method for producing an ultrafine-bubble-containing liquid includes: supplying a liquid containing at least one substance selected from a group stated below to a liquid supply region where an ejection orifice forming member in which an ejection orifice with a minute diameter is formed is disposed; and ejecting the liquid from the ejection orifice as a droplet by causing a pressure application unit in contact with the liquid to apply pressure to the liquid supplied to the liquid supply region. The group consists of a thermally denaturing material, inorganic salts, amino acids and their salts, carbohydrates/sugars and their salts, organic polymers and their salts, inorganic polymers and their salts, a dispersion, and an organic liquid.
PROCESSES AND SYSTEMS FOR METABOLITE PRODUCTION USING HYDROGEN RICH C1-CONTAINING SUBSTRATES
The invention is directed to a process for producing one or more fermentation product in a multi-stage process including an inoculation reactor and at least one bioreactor. The inoculation reactor is fed a C1-containing gaseous substrate containing a reduced amount of hydrogen. The hydrogen is reduced to increase the proportion of CO in the C1-containing gaseous substrate being provided to the inoculation reactor. The inoculation reactor ferments the CO-rich C1-containing gaseous substrate and produces an inoculum, which is fed to at least one bioreactor. The bioreactor receives the C1-containing gaseous substrate, which may or may not contain reduced amounts of hydrogen, to produce one or more fermentation product. By providing a CO-rich C1-containing gaseous substrate to the inoculation reactor, both the inoculation reactor and the subsequent bioreactor(s), are able to have increased stability and product selectivity.